USPTO serial 86910264
CERES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 14, 2017
- Examiner
- KENEALY, NATALIE LANGFORD
- Law office
- TMEG LAW OFFICE 104
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CERES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | housemark for homeopathic pharmaceutical preparations, excluding antihistamines and excluding diet products for specific medical nutrition, for use in the treatment of a variety of gastrointestinal diseases and conditions, namely, indigestion, heartburn, sour stomach, upset stomach, gas, diarrhea, over indulgence in food and drink, anorexia, bowel irritation and abrasion, hemorrhoidal inflammation and irritation, and anorectal inflammation, but specially excluding homeopathic pharmaceutical preparations used as diet products for specific medical nutrition, for use in the treatment of a variety of dermatologic diseases and conditions, namely, for use in the treatment skin pain, discomfort and itching due to abrasions, burns, fungal infections, eczema, psoriasis, atopic dermatitis, plant toxins and insect bites, and for use in the treatment of hyperpigmentation, scarring acne, dandruff, seborrheic dermatitis, cold sores, fever blisters, fungal infections, warts, and calluses, for use in the treatment of motion sickness, for use in the treatment of sleeplessness and insomnia, for use in the treatment of fatigue and drowsiness, for use in the treatment of bacterial infections, viral infections, swollen lymph glands, fever, pain, allergic rhinitis, chest congestion, coughs, bronchitis, and the common cold, but specifically excluding anti-histamines, for use in the treatment of asthma, for use in the prevention and treatment of cardiovascular disease, for use in the treatment of joint, tendon, ligament and muscle pain and stiffness, for use in the treatment of arthritis and rheumatism, for use in the treatment of a variety of ophthalmic conditions, namely, eye burning, eye irritation, eye strain, and eye discomfort, for use in the treatment of a variety of oral conditions, namely, tooth decay, gingivitis, oral abrasions, wounds, and dry mouth, used for anthelmintic purposes, namely, to expel parasitic worms and parasites, for the treatment of gynecological disorders, namely, pain and discomfort of menses, menopause, and intercourse, for the treatment of urological disorders, namely, urinary tract pain, and frequent urination, for use in the treatment of allergies and hay fever, but specially excluding antihistamines, for the treatment of bloating, pain, indigestion, and discomfort associated with liver disorders; homeopathic pharmaceutical preparations for use in the treatment of a variety of gastrointestinal diseases and conditions, namely, indigestion, heartburn, sour stomach, upset stomach, gas, diarrhea, over indulgence in food and drink, anorexia, bowel irritation and abrasion, hemorrhoidal inflammation and irritation, and anorectal inflammation, but specially excluding homeopathic pharmaceutical preparations used as diet products for specific medical nutrition; homeopathic pharmaceutical preparations for use in the treatment of a variety of dermatologic diseases and conditions, namely, for use in the treatment skin pain, discomfort and itching due to abrasions, burns, fungal infections, eczema, psoriasis, atopic dermatitis, plant toxins and insect bites, and for use in the treatment of hyperpigmentation, scarring acne, dandruff, seborrheic dermatitis, cold sores, fever blisters, fungal infections, warts, and calluses; homeopathic pharmaceutical preparations for use in the treatment of motion sickness; homeopathic pharmaceutical preparations for use in the treatment of sleeplessness and insomnia; homeopathic pharmaceutical preparations for use in the treatment of fatigue and drowsiness; homeopathic pharmaceutical preparations for use in the treatment of bacterial infections, viral infections, swollen lymph glands, fever, pain, allergic rhinitis, chest congestion, coughs, bronchitis, and the common cold, but specifically excluding anti-histamines; homeopathic pharmaceutical preparations for use in the treatment of asthma; homeopathic pharmaceutical preparations for use in the prevention and treatment of cardiovascular disease; homeopathic pharmaceutical preparations for use in the treatment of joint, tendon, ligament and muscle pain and stiffness, and for use in the treatment of arthritis and rheumatism; homeopathic pharmaceuticals for use in the treatment of a variety of ophthalmic conditions, namely, eye burning, eye irritation, eye strain, and eye discomfort; homeopathic pharmaceuticals for use in the treatment of a variety of oral conditions, namely, tooth decay, gingivitis, oral abrasions, wounds, and dry mouth; homeopathic pharmaceutical preparations used for anthelmintic purposes, namely, to expel parasitic worms and parasites; homeopathic preparations for the treatment of gynecological disorders, namely, pain and discomfort of menses, menopause, and intercourse; homeopathic preparations for the treatment of urological disorders, namely, urinary tract pain, and frequent urination; homeopathic pharmaceutical preparations for use in the treatment of allergies and hay fever, but specially excluding antihistamines; homeopathic pharmaceutical preparations for the treatment of bloating, pain, indigestion, and discomfort associated with liver disorders | ACTIVE | May 31, 2005 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 15, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Oct 29, 2022 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Oct 29, 2022 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Oct 29, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 17, 2022 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Feb 14, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 13, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 14, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 11, 2017 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 10, 2017 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 22, 2016 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 22, 2016 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 1, 2016 | IUAF | USE AMENDMENT FILED | — |
| Dec 1, 2016 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 1, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 6, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 22, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 7, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 2, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 23, 2016 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 23, 2016 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 23, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2016 | NWAP | NEW APPLICATION ENTERED | — |